These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 12579402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypocitraturia: a risk factor for reduced bone mineral density in idiopathic hypercalciuria?
    Penido MG, Lima EM, Souto MF, Marino VS, Tupinambá AL, França A.
    Pediatr Nephrol; 2006 Jan; 21(1):74-8. PubMed ID: 16252112
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone mineral density in pediatric patients with idiopathic hypercalciuria.
    García-Nieto V, Ferrández C, Monge M, de Sequera M, Rodrigo MD.
    Pediatr Nephrol; 1997 Oct; 11(5):578-83. PubMed ID: 9323283
    [Abstract] [Full Text] [Related]

  • 6. BONE MINERAL DENSITY IN CHILDREN WITH IDIOPATHIC HYPERCALCIURIA.
    Artemiuk I, Pańczyk-Tomaszewska M, Adamczuk D, Przedlacki J, Roszkowska-Blaim M.
    Dev Period Med; 2015 Oct; 19(3 Pt 2):356-61. PubMed ID: 26958681
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria.
    Vezzoli G, Rubinacci A, Bianchin C, Arcidiacono T, Giambona S, Mignogna G, Fochesato E, Terranegra A, Cusi D, Soldati L.
    Am J Kidney Dis; 2003 Dec; 42(6):1177-83. PubMed ID: 14655189
    [Abstract] [Full Text] [Related]

  • 10. Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis.
    Tasca A, Cacciola A, Ferrarese P, Ioverno E, Visonà E, Bernardi C, Nobile M, Giannini S.
    Urology; 2002 Jun; 59(6):865-9; discussion 869. PubMed ID: 12031370
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
    Krupa B.
    Ann Acad Med Stetin; 2000 Jun; 46():165-76. PubMed ID: 11712302
    [Abstract] [Full Text] [Related]

  • 12. The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.
    Arrabal-Martin M, Poyatos-Andujar A, Cano-García Mdel C, Quesada-Charneco M, Abad-Menor F, Girón Prieto MS, de Haro Muñoz T, Arrabal-Polo MA.
    Int Urol Nephrol; 2015 Mar; 47(3):445-9. PubMed ID: 25652872
    [Abstract] [Full Text] [Related]

  • 13. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 15. Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.
    Girón-Prieto MS, Arias-Santiago S, Del Carmen Cano-García M, Poyatos-Andújar A, de Haro-Muñoz T, Abad-Menor F, Quesada-Charneco M, Arrabal-Polo MÁ, Arrabal-Martín M.
    Int Urol Nephrol; 2016 Nov; 48(11):1777-1781. PubMed ID: 27376897
    [Abstract] [Full Text] [Related]

  • 16. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR, Hamdy NA, Janssen YJ, Roelfsema F.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [Abstract] [Full Text] [Related]

  • 17. Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents?
    Penido MGMG, Tavares MS.
    World J Nephrol; 2021 Jul 25; 10(4):47-58. PubMed ID: 34430384
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonates in children with hypercalciuria and reduced bone mineral density.
    Freundlich M, Alon US.
    Pediatr Nephrol; 2008 Dec 25; 23(12):2215-20. PubMed ID: 18704505
    [Abstract] [Full Text] [Related]

  • 19. [Idiopathic hypercalciuria and bone density].
    Daragon A, Dhib M, Morin JP, Godin M, Fillastre JP.
    Rev Rhum Mal Osteoartic; 1992 Jan 25; 59(1):35-8. PubMed ID: 1579844
    [Abstract] [Full Text] [Related]

  • 20. Bone mineral density and bone turnover in patients with Bartter syndrome.
    Rodríguez-Soriano J, Vallo A, Aguirre M.
    Pediatr Nephrol; 2005 Aug 25; 20(8):1120-5. PubMed ID: 15942790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.